Skip to main content

Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology, will represent the Company in a session scheduled at 4:20 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  207.98
-3.73 (-1.76%)
AAPL  253.91
+1.29 (0.51%)
AMD  204.02
-16.25 (-7.38%)
BAC  48.23
-0.52 (-1.06%)
GOOG  280.77
-8.81 (-3.04%)
META  546.81
-48.08 (-8.08%)
MSFT  365.84
-5.20 (-1.40%)
NVDA  171.84
-6.84 (-3.83%)
ORCL  143.25
-2.77 (-1.90%)
TSLA  372.77
-13.18 (-3.41%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.